The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia.
Mahipal
Amit
A
Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Weiss
Mark
M
J Clin Oncol. 2006 Apr 1;24(10):1575-81
16520464
J Clin Oncol. 2003 Apr 1;21(7):1278-84
12663715
J Clin Oncol. 2010 Apr 1;28(10):1756-65
20194844
Blood. 2006 Feb 1;107(3):885-91
16219797
Lancet. 2008 Mar 22;371(9617):1017-29
18358929
J Clin Oncol. 2005 Jun 20;23(18):4070-8
15767647
J Clin Oncol. 2009 Feb 1;27(4):491-7
19075280
J Clin Oncol. 2009 Feb 1;27(4):498-503
19075274
Blood. 2009 Oct 15;114(16):3382-91
19605849
Blood. 2008 Aug 15;112(4):975-80
18411418